(4) D K Sinha, A Balasubramanian, A J Tatem, J Rivera-Mirabal, et al (2020) Beyond the androgen receptor: the role of growth hormone secretagogues in the modern management of body composition in hypogonadal males Translational Andrology Urology, 2020 Mar, Volume 9 (Suppl 2), Pages S149S159
Same molecule as the vial, but in the easy-to-use injector
(Wada-Ama) FDA flags BPC-157 as a Category 2 bulk drug substance under 503A with concerns about immunogenicity, impurities, and limited safety information
This typically lasts 5-15 minutes and is considered a normal physiological response rather than a concerning side effect
Key Industry Highlights Dominant Region : North America is set to command approximately 30% of the market share in 2025